HOME / ¹®¼°øÀ¯ / ¸®Æ÷Æ®/³í¹® / ±â¼ú°øÇÐ
0
µî·ÏÀÚ
ky*****
µî±Þº° ÇýÅú¸±â
HLA Çüº°°Ë»ç¿¡ °üÇÑ ÂüÁ¶ÀÚ·áÀÔ´Ï´Ù.
HLA ±³Â÷½ÃÇè
MHCMajor Histocompatiblity ComplexÀÇ ÀÌÇØ
BÇü°£¿°ÀÇ Ç÷ûÇÐÀû Ç¥ÁöÀÚ °Ë»ç¸¦ À§ÇÑ Á¤·®Àû È¿¼Ò¸é¿ª¹ý°ú ÈÇй߱¤¸é¿ª¹ý
Ç°Áú°Ë»çÀǹæ¹ý
¾Æµ¿°Ë»ç°³·Ð
¹ß´Þ°Ë»çÀÇ Á¾·ù¿Í °³³ä
ö°ñ°øÀå ½ÃÇè ¹× °Ë»çÀÛ¾÷ÀýÂ÷¼
ºñÆı«°Ë»ç ½Å·Úµµ Çâ»ó º¸°í¼
¾Æµ¿°Ë»ç¾Æµ¿´ë»ó °Ë»ç½Ã°í·Á»çÇ×
±âÃÊ ÇнÀ±â´É °Ë»ç
¼º°Ý°Ë»ç°³¿ä
¼º°Ý°Ë»ç Á¾·ù2
¼º°Ý°Ë»ç¼º°ÝÆò°¡¹æ¹ý
¼º°Ý°Ë»çÁöÇÊ°Ë»ç,Åõ»ç¹ý
MICU¿¡¼ ÇÏ´Â Æó±â´É Ư¼ö°Ë»ç
µ§¹ö ¹ß´Þ¼±º° °Ë»çÀÇ Á¾·ù
Ç¥ÁØȰ˻翡 °üÇÑÀïÁ¡»çÇ×
½É¸®°Ë»çÀÇ ±â´É¹× º»Áú ½É¸®°Ë»çÀÇ À¯Çü
¾Æµ¿°Ë»ç°³¿ä
½É¸®°Ë»çÀÇ ½Ç½Ã°úÁ¤°ú °³¹ß°úÁ¤
ȯ°æ½ÃÇè°Ë»ç ¹ßÀü±âº»°èȹ ¼ö¸³À» À§ÇÑ ¿¬±¸º¸°í¼
Áö´É ÃøÁ¤°Ë»çÀÇ Á¾·ù
Á÷¾÷Èï¹Ì°Ë»ç
½É¸®°Ë»çÀÇ À¯Çü
GATB Àû¼º°Ë»ç ºÐ¼® º¸°í
°Ë»ç¾÷¹«±ÔÁ¤ÀýÂ÷¼
¾Æµ¿½É¸®°Ë»ç ¼±Åýà °í·Á»çÇ×
Çо÷¼ºÃë°Ë»çÀÇ Á¾·ù¿Í ³»¿ë
·Î»þ °Ë»çRorschach TestÀÇ ÀÌÇØ
»êÀü°Ë»ç°¡À̵å¶óÀÎ ¼³Á¤À» À§ÇÑ ±âÃÊÁ¶»ç º¸°í¼
ÇØ»ç¹ý·É °³·Ð¼±¹Ú¾ÈÀü¹ý ¹× °¢Á¾ °Ë»ç °ü·Ã
µ¿¸ÆÇ÷±âü°Ë»çABGA¿¡ µû¸¥ Á¶Ä¡
°Ë»ç¹× ½ÃÇè¾÷¹« ÇÁ·Î¼¼½º¼öÀÔ°Ë»ç
°Ë»ç¾÷¹« ±ÔÁ¤
Æı«°Ë»ç ºñÆı«°Ë»ç
¼º°Ý°Ë»çÁ¾·ù
»ó´ãÀ» À§ÇÑ ½É¸®°Ë»çÀÇ È°¿ë°³·Ð
Áö´É°Ë»çÀÇÁ¾·ù
½ÃÁö°¢¹ß´Þ°Ë»ç
´ç´¢º´ÀÇ Áø´Ü¹æ¹ý
·Î»þ °Ë»ç ÁÖÁ¦Åë°¢ °Ë»çTAT BGTBender-Gestalt Test
Ç×°ø¿ìÁÖÀÇÇйßÀü ¹× Ç×°ø½Åü°Ë»ç Á¦µµ°³¼±¹æ¾È º¸°í¼
¾Æµ¿¿¬±¸¿Í ½É¸®°Ë»çÁö´É°Ë»ç ¼º°Ý°Ë»ç Åõ½Ã°Ë»ç
¾Æµ¿¿¬±¸¿Í ½É¸®°Ë»çƯ¼º ¿ª»ç ¹®Á¦Á¡
Á¢Ã˼º½Ã°¢ º¯º°·Â °Ë»çHVDT
À¡½½·¯ Áö´É°Ë»ç
¾Æµ¿¿ë½É¸®°Ë»ç ¹èÅ͸®
K-WAIS Áö´É°Ë»ç-À¡½½·¯ ¼ºÀοëÁö´É°Ë»ç
À¯ÇØÀ§Çè±â°è±â±¸ °Ë»çÁ¦µµ
Ȧ·£µåÁ÷¾÷Àμº ÀÌ·Ð
À¡½½·¯¼ºÀοë Áö´É°Ë»çK-WAIS
Áö´ÉÁö¼ö¿¡ ´ëÇÑ Á¤ÀÇ¿Í Çؼ®
¼ºÀαâ ÁöÀû¹ß´Þ¼ºÀαâ Áö´É°Ë»çÀÇÁ¾·ù
CIS-ACommunity Integration Skills-Assessment Áö¿ª»çȸÀûÀÀ°Ë»ç1
¹ÝÀÀ¼º ¾ÖÂøÀå¾ÖÀÇ Æ¯Â¡°ú ½É¸®ÇÐÀû Æò°¡
ÇнÀÀå¾ÖÀÇ ºÐ·ù¿Í ½É¸®Àû Æò°¡ ¹æ¹ý
Áö´É°Ë»çÀÇ À¯Çü
Áö´É°Ë»çÀÇ Á¾·ù¿Í ¼ºÀαâÀÇ Â¡´É°Ë»ç
Áö´ÉÀÇ º»Áú°ú Áö´É°Ë»çÀÇ ¹ßÀü¹è°æ
Ç°Áú°Ë»ç±â¹ý°í±Þ
µµÃà°Ë»ç½Ç½À ¿¬±¸º¸°í¼
Áö´ÉÀ̷аú °áÁ¤¿äÀÎ ¹× Áö´É°Ë»çÀÇ °³³ä
°É¼³Àåºñ ÀÚü°Ë»ç°á°ú¼ ¾ç½Ä
»ùÇøµ°Ë»ç
ºñÆı«°Ë»çnondestructive testing/NDT
Ç×°ø½Åü°Ë»çÁõ¸í ¼¼ºÎÆÇÁ¤±âÁØ ¾÷¹«¸Å´º¾ó
±â°è¾ÈÀü-ÃÊÀ½ÆÄ Å½»ó°Ë»ç& ÇÁ·¢Å»[fractal] Â÷¿ø
Non Destructive Testing[NDT]-ºñÆı« °Ë»çÀÇ Á¾·ù¿Í Á¤ÀÇ
°À籸Á¶¹° ºñÆı«°Ë»çÀÇ Á¾·ù¿Í Àû¿ë
±¹³»¿ÜµµÃà°Ë»çÁ¦µµ º¸°í¼2006³â
Ä«¿ìÇÁ¸¸ ¾Æµ¿Áö´É°Ë»ç ¼Ò°³ ¹× ±¹³» ½ÇÁ¤¿¡ ¸Â´Â Àû¿ë ¹æ¾È
û¼Ò³âü·ÂÁõÁøÀ» À§ÇÑ Çлýü·Â °Ë»çÁ¦µµ °³¼±¿¬±¸ º¸°í¼
»ý¸í°ú Áúº´Áø´Ü°Ë»çÀÇÇÐ
Çѱ¹°ú ¹Ì±¹ÀÇ Ç¥ÁØÈ°Ë»ç¿Í Çо÷¼ºÃëµµÆò°¡ÀÇ ºñ±³
SELSI ¿µÀ¯¾Æ¾ð¾î¹ß´Þ °Ë»ç
Ãʵµ ºÎÇ°°Ë»ç ¼ºÀû¼ISIR °Ë»çÇùÁ¤ ä°á¼
°ü»óµ¿¸Æ Á¶¿µ¼ú CAGCoronary Angiography
¹ÞÀº º°Á¡
0/5
0°³ÀÇ º°Á¡
¹®¼°øÀ¯ ÀڷḦ µî·ÏÇØ ÁÖ¼¼¿ä.¹®¼°øÀ¯ Æ÷ÀÎÆ®¿Í Çö±ÝÀ» µå¸³´Ï´Ù.
Æ÷ÀÎÆ® : ÀÚ·á 1°Ç´ç ÃÖ´ë 5,000P Áö±Þ
Çö±Ý : ÀÚ·á 1°Ç´ç ÃÖ´ë 2,000¿ø Áö±Þ
ÈıâÀÛ¼º»ç¿ëÈı⸦ ÀÛ¼ºÇÏ½Ã¸é ¹®¼°øÀ¯ 100 point¸¦ Àû¸³ÇØ µå¸³´Ï´Ù.
0/120
»ç¿ëÈıâ (0)
µî·ÏµÈ ¸®ºä°¡ ¾ø½À´Ï´Ù.
ù¹ø° ¸®ºä¾î°¡ µÇ¾îÁÖ¼¼¿ä.
¾ÆÀ̵ð ã±â°¡ µÇÁö ¾Ê´Â´Ù¸é °í°´¼¾ÅÍ·Î ¿¬¶ôÁֽñ⠹ٶø´Ï´Ù.
ÀÔ·ÂÇϽŠÁ¤º¸·Î °¡ÀÔµÈ ¾ÆÀ̵𰡠¾ø½À´Ï´Ù.
ºñ¹Ð¹øÈ£ ã±â°¡ µÇÁö ¾Ê´Â´Ù¸é °í°´¼¾ÅÍ·Î ¿¬¶ôÁֽñ⠹ٶø´Ï´Ù.